Dr. Ronda Marie Chakolis-Hassan

They have other indications, some of the medications that are used for mental health.

They have other FDA indications.

I think the bigger conversation is kind of back to what this show is about.

Let's chatter about health.

Let's talk about what health actually means.

I would like to go back to just one thing and kind of pick on my colleague here or your colleague here, Mr. Clarence Jones.

One thing is informing people about things.

So for example, I know he is very active in the community and helping people understand their medications.

And really in particular with the GLP-1s, I know he has started to do some work that GLP-1 is in your body naturally.

um there's the mind gut body connection and so really i know some of the work he's been doing is really talking to people about protein healthy fats fiber fermented foods and timing glp-1 that mechanism of action is actually naturally in your body and so when you

Kind of pair that with the natural things in the medication, you'll probably get results or even looking at how do you capitalize on that natural effect.

In terms of you said something that I was very passionate about in my pharmacy studies, I did a lot of research or research.

information around cost and orphan drugs, right?

Again, we need to understand, too, the cost of research.

We haven't really had a whole lot of good data surrounding that.

People will say that, you know, it's millions of dollars to get a drug from pipeline in the pipeline to patient.

But again, there's all of these different mechanisms that people can do to get them there.

So for example, GLP-1s are not anything new.

They've been around for decades.

There just has been a market for them and increasing them.